Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07143019 · ClinicalTrials.gov registry record · NA
The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms
A NA study of Hemorrhagic Stroke and Aneurysm, Intracranial, sponsored by phenox.
- Recruiting
- Registry status
- NA
- Development phase
- 214
- Enrollment target
- 8
- Study locations
NCT07143019: Recruiting NA study of Hemorrhagic Stroke and Aneurysm, Intracranial, sponsored by phenox.
NCT07143019 is a NA study of Hemorrhagic Stroke and Aneurysm, Intracranial that is actively recruiting participants, run by phenox. The registered enrollment target is 214 participants, below the 10,362-participant average among 6 other Hemorrhagic Stroke trials with a reported enrollment target (98% lower). The trial reports 8 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07143019, a NA study of Hemorrhagic Stroke and Aneurysm, Intracranial, is actively recruiting participants, sponsored by phenox.
- RECRUITING
- Registry status
- NA
- Development phase
- 214 participants
- Enrollment target
- 8
- Study locations
Study Summary
To determine safety and effectiveness of the p48 MW HPC and p64 MW HPC flow diverter in the treatment of wide-necked intracranial aneurysms.
Primary Outcome
The Primary Efficacy and Performance Endpoint is a composite of 100% target aneurysm occlusion (Raymond-Roy Class I) without significant stenosis (defined as ≤50% stenosis) of the parent artery based on independent core lab evaluation of the 12-month follow-up angiogram (DSA), and no subsequent treatment at the target aneurysm at the 12-month follow-up visit.
Conditions Studied
Interventions
- DEVICE Flow diversion
Study Locations (8)
Colorado
- University of Colorado Anschutz - Aurora
- Swedish Medical Research Center - Englewood
New York
- UBNS - Buffalo
- North Shore University Hospital - Northwell Health - Manhasset
Arizona
- Barrow Neurological Institute - Phoenix
Florida
- Baptist Health Research Institute - Jacksonville
Massachusetts
- Tufts Medical Center - Boston
Washington
- University of Washington - Harborview Medical Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 214 participants |
| Start Date | 2026-02 |
| Est. Completion | 2032-06 |
| Phase | NA |
What NCT07143019 shows while recruiting
NCT07143019 is an interventional study that assigns participants to a tested intervention. The registered 214 participants enrollment target is mid-sized for trials with a published cap, below the 10,362-participant average among 6 other Hemorrhagic Stroke trials with a reported enrollment target (98% lower).
The record links to 5 conditions, with Hemorrhagic Stroke appearing as the primary indexed condition, and to 1 intervention - of which Flow diversion is the first listed.
NCT07143019 lists 8 locations in 6 states (Colorado, New York, Arizona).
Frequently Asked Questions
What is clinical trial NCT07143019 about?
NCT07143019 is a clinical study titled "The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms". To determine safety and effectiveness of the p48 MW HPC and p64 MW HPC flow diverter in the treatment of wide-necked intracranial aneurysms.
What is the current status of trial NCT07143019?
This trial is currently recruiting. It is a NA study. The enrollment target is 214 participants. The study started on 2026-02. Estimated completion is 2032-06.
What conditions does trial NCT07143019 study?
This clinical trial studies the following conditions: Hemorrhagic Stroke, Aneurysm, Intracranial, Brain Aneurysm, Saccular Aneurysm, Fusiform Aneurysm.
What interventions are being tested in trial NCT07143019?
The interventions under investigation include: Flow diversion (DEVICE).
Who is sponsoring clinical trial NCT07143019?
This trial is sponsored by phenox, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07143019 being conducted?
This trial has 8 study locations across Arizona, Colorado, Florida, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hemorrhagic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition
RECRUITING · NA
-
Wireless Nerve Stimulation Device To Enhance Recovery After Stroke
RECRUITING · NA
-
Left Atrial Strain and Cryptogenic Stroke
RECRUITING
-
Stroke Recovery Initiative - Registry for Stroke Research Studies
RECRUITING
-
Diagnostic Performance Study of the EMVision Emu™ Brain Scanner in the Detection of Intracranial Hemorrhage in Suspected Stroke Patients
RECRUITING
-
Efficacy, Safety and Tolerability of BAF312 Compared to Placebo in Patients With Intracerebral Hemorrhage (ICH).
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04030507 · 214 participants · NA
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
- NCT04421248 · 214 participants · Phase 4
Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder
- NCT04667520 · 214 participants · NA
Testing a Lifestyle Physical Activity Intervention for Women With Depression in Alcohol Treatment
- NCT05418868 · 214 participants · Phase 1
A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia